191 related articles for article (PubMed ID: 2142603)
1. Protective effects of D-Trp6-luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats.
Bokser L; Szende B; Schally AV
Br J Cancer; 1990 Jun; 61(6):861-5. PubMed ID: 2142603
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
Schally AV; Redding TW
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of analogs of luteinizing hormone-releasing hormone against chemotherapy-induced testicular damage in rats.
Karashima T; Zalatnai A; Schally AV
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2329-33. PubMed ID: 2965391
[TBL] [Abstract][Full Text] [Related]
4. D-Tryptophan-6 analog of luteinizing hormone-releasing hormone as a protective agent against testicular damage caused by cyclophosphamide in baboons.
Lewis RW; Dowling KJ; Schally AV
Proc Natl Acad Sci U S A; 1985 May; 82(9):2975-9. PubMed ID: 3157995
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of analogs of luteinizing hormone-releasing hormone against x-radiation-induced testicular damage in rats.
Schally AV; Paz-Bouza JI; Schlosser JV; Karashima T; Debeljuk L; Gandle B; Sampson M
Proc Natl Acad Sci U S A; 1987 Feb; 84(3):851-5. PubMed ID: 2949328
[TBL] [Abstract][Full Text] [Related]
6. Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model.
Schally AV; Kook AI; Monje E; Redding TW; Paz-Bouza JI
Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8764-8. PubMed ID: 2946045
[TBL] [Abstract][Full Text] [Related]
7. Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model.
Schally AV; Redding TW
Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2498-502. PubMed ID: 3157990
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.
Redding TW; Schally AV
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6509-12. PubMed ID: 6458815
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of growth of a prolactin and growth hormone-secreting pituitary tumor in rats by D-tryptophan-6 analog of luteinizing hormone-releasing hormone.
Torres-Aleman I; Redding TW; Schally AV
Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1252-6. PubMed ID: 2858096
[TBL] [Abstract][Full Text] [Related]
10. Recovery of pituitary-gonadal function in male and female rats after prolonged administration of a potent antagonist of luteinizing hormone-releasing hormone (SB-75).
Bokser L; Srkalovic G; Szepeshazi K; Schally AV
Neuroendocrinology; 1991 Aug; 54(2):136-45. PubMed ID: 1662786
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoassay for 6-D-tryptophan analog of luteinizing hormone-releasing hormone: measurement of serum levels after administration of long-acting microcapsule formulations.
Mason-Garcia M; Vigh S; Comaru-Schally AM; Redding TW; Somogyvari-Vigh A; Horvath J; Schally AV
Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1547-51. PubMed ID: 3156381
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the growth of some hormone dependent tumors by D-Trp6-LH-RH.
Schally AV; Redding TW; Comaru-Schally AM
Med Oncol Tumor Pharmacother; 1984; 1(2):109-18. PubMed ID: 6242477
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone.
Redding TW; Schally AV
Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1459-62. PubMed ID: 6219395
[TBL] [Abstract][Full Text] [Related]
14. Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules.
Redding TW; Schally AV; Tice TR; Meyers WE
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5845-8. PubMed ID: 6237365
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of a highly potent antagonist of LH releasing hormone (SB-75) on the pituitary gonadal axis in the intact and castrated rat.
Ayalon D; Farhi Y; Comaru-Schally AM; Schally AV; Eckstein N; Vagman I; Limor R
Neuroendocrinology; 1993 Aug; 58(2):153-9. PubMed ID: 8264861
[TBL] [Abstract][Full Text] [Related]
16. Prolonged suppression of plasma LH levels in male rats after a single injection of an LH-RH agonist in poly(DL-lactide-co-glycolide) microcapsules.
Asch RH; Rojas FJ; Bartke A; Schally AV; Tice TR; Klemcke HG; Siler-Khodr TM; Bray RE; Hogan MP
J Androl; 1985; 6(2):83-8. PubMed ID: 3157667
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of precocious puberty with an LH-RH agonist (D-TRP6-LH-RH delayed-release microcapsules)].
Canlorbe P; Chaussain JL; Lahlou N; Roger M; Toublanc JE; Job JC
Bull Acad Natl Med; 1988 Nov; 172(8):1091-8. PubMed ID: 2977732
[No Abstract] [Full Text] [Related]
18. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
Radulovic S; Comaru-Schally AM; Milovanovic S; Schally AV
Pancreas; 1993 Jan; 8(1):88-97. PubMed ID: 8093555
[TBL] [Abstract][Full Text] [Related]
19. Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.
Li X; Kang X; Deng Q; Cai J; Wang Z
Reprod Biol Endocrinol; 2013 Mar; 11():16. PubMed ID: 23452939
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the combination of the agonist D-Trp-6-LH-RH and the antiandrogen flutamide in the treatment of Dunning R-3327H prostate cancer model.
Redding TW; Schally AV
Prostate; 1985; 6(3):219-32. PubMed ID: 3157927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
